Robert Beardsley Email & Phone Number
@galeratx.com
5 phones found area 410, 314, and 610
LinkedIn matched
Who is Robert Beardsley? Overview
A concise factual answer block for searchers comparing this professional profile.
Robert Beardsley is listed as CEO/COO - catalysing start-up, scaling, transformation and performance of innovative biopharma companies. at Arbutus Biopharma Corporation, a with 62 employees, based in Greater Philadelphia, United States. AeroLeads shows a work email signal at galeratx.com, phone signal with area code 410, 314, 610, and a matched LinkedIn profile for Robert Beardsley.
Robert Beardsley previously worked as Co-Founder, Executive Chair & Chief Operating Officer at Galera Therapeutics, Inc. and Member, Board of Directors at Euclises Pharmaceuticals, Inc.. Robert Beardsley holds Mba, Finance/International Business from The University Of Chicago Booth School Of Business.
Email format at Arbutus Biopharma Corporation
This section adds company-level context without repeating Robert Beardsley's masked contact details.
AeroLeads found 2 current-domain work email signals for Robert Beardsley. Compare company email patterns before reaching out.
About Robert Beardsley
Chief Executive Officer/Chief Operating Officer with PhD and 30+ years of creating and leading complex, highly successful public and private sector biopharma companies. Leverage broad experience across the science and business of biopharma discovery/development with proven commercial acumen, along with strong team-building and leadership, to spearhead start-up, scale-up, and sustainable rapid growth.Combine a sharp business acumen and strong scientific understanding to lead a holistic approach to key business opportunities and challenges, inspire innovation, and be a strategic partner with board, investors, and partners. Core to this is a focus on consistently creating value for shareholders, and importantly, radically improving outcomes for patients, while inspiring the team to the mission. Achieve these while building diverse and inclusive industry-leading teams, fostering rewarding and results-oriented cultures to maximize engagement and productivity, and leading by example. Result is a demonstrated ability to drive strategy, a strong organization, multiple rounds of funding and the delivery of patient-centric solutions.Experience in a wide variety of settings: start-up through public company and M&A; product and platform; oncology and broad range of other therapeutic areasNotable recent successes include co-leadership of Galera from conception through filing of lead candidate NDA, securing $150m+ in venture funding up through Series C while concurrently guiding a potentially $1b+ lead clinical asset through Phase 3, and orchestrating a timely and effective $60m IPO despite highly challenging market conditions.Specialities:Corporate Strategy | Board Leadership | Investor/Shareholder Relations | Partnering/Collaborations | Team Recruitment/Culture | Coaching/Mentoring | Discovery | Nonclinical Science | CMC | Clinical Development | Commercialization | Intellectual Property | Cybersecurity | Risk Analysis/Mitigation | Crisis Management | Issue Resolution |
Listed skills include Lifesciences, Biotechnology, Pharmacology, Life Sciences, and 14 others.
Robert Beardsley's current company
Company context helps verify the profile and gives searchers a useful next step.
Robert Beardsley work experience
A career timeline built from the work history available for this profile.
Co-Founder, Executive Chair & Chief Operating Officer
CurrentHave worn many hats within Galera – (GRTX) – serving as co-Founder, Chair, CEO, and board member before moving into Exec Chair & (now) COO roles. The consistent focus in these roles has been to drive growth and innovation by shaping strategy, securing funding, leading R&D, expanding market opportunity and extending market exclusivity. Have managed 30+ cross-functional specialists, coached executives, ensured business-wide buy-in for the overall mission of improving outcomes for cancer patients, and continually improved development, clinical and commercial areas.◼️ Drove Galera’s start-up and success by executing leading-edge strategy, creating a robust business environment, and delivering change, including recruiting a CEO for succession planning and building core functional areas from the ground-up, including people, processes, and systems.◼️Accelerated business growth by designing development path for lead candidate and successfully co-managing execution from selection through pending NDA submission, securing patents and extending market exclusivity for that asset, and discovering and rebranding second candidate, resulting in a combined $150m raised through seed, Series A and B, and crossover Series C fundraising rounds.◼️ Worked closely with CEO and CBO to secure $117M in royalty deals facilitating Phase 3 trial, and timely $60m IPO against challenging conditions that saw contemporary IPOs pulled.◼️ Partnered with Chief Regulatory Affairs Officer to file first NDA for lead candidate, and to open approval path to second indication for that candidate in chronic kidney disease.◼️ Collaborated with leading academic researchers and corporate partners identifying new technology applications and dramatically expanding product market opportunities. ◼️ Spearheaded crisis management, including the rapid resolution of a clinical hold on Phase 3 during IPO process within 3 months, enabling continuation of both and even securing additional patent coverage.
Member, Board Of Directors
CurrentChair, Board of Directors - 2013 to 2014
Acting Chief Business Officer
Confluence was acquired by Aclaris Therapeutics Inc. (NNM: ACRS) in August 2017.
President & Ceo
Member, Board Of Directors
Bioseek was acquired by Asterand PLC (LSE: ATD) in December 2009.
Member, Board Of Directors
Collagenex (NNM: CGPI) was acquired by Galerderma Pharma SA in 2008.
Managing Member
Acting Ceo
Board Member
Principal
Equity Research Associate
Robert Beardsley education
Mba, Finance/International Business
Phd, Biochemical Engineering
Phd, Biochemical Engineering
Bsche, Chemical Engineering
Master Of Business Administration - Mba, Finance And International Business
Frequently asked questions about Robert Beardsley
Quick answers generated from the profile data available on this page.
What company does Robert Beardsley work for?
Robert Beardsley works for Arbutus Biopharma Corporation.
What is Robert Beardsley's role at Arbutus Biopharma Corporation?
Robert Beardsley is listed as CEO/COO - catalysing start-up, scaling, transformation and performance of innovative biopharma companies. at Arbutus Biopharma Corporation.
What is Robert Beardsley's email address?
AeroLeads has found 2 work email signals at @galeratx.com for Robert Beardsley at Arbutus Biopharma Corporation.
What is Robert Beardsley's phone number?
AeroLeads has found 5 phone signal(s) with area code 410, 314, 610 for Robert Beardsley at Arbutus Biopharma Corporation.
Where is Robert Beardsley based?
Robert Beardsley is based in Greater Philadelphia, United States while working with Arbutus Biopharma Corporation.
What companies has Robert Beardsley worked for?
Robert Beardsley has worked for Arbutus Biopharma Corporation, Galera Therapeutics, Inc., Euclises Pharmaceuticals, Inc., Confluence Life Sciences, Inc., and Kempharm Inc..
How can I contact Robert Beardsley?
You can use AeroLeads to view verified contact signals for Robert Beardsley at Arbutus Biopharma Corporation, including work email, phone, and LinkedIn data when available.
What schools did Robert Beardsley attend?
Robert Beardsley holds Mba, Finance/International Business from The University Of Chicago Booth School Of Business.
What skills is Robert Beardsley known for?
Robert Beardsley is listed with skills including Lifesciences, Biotechnology, Pharmacology, Life Sciences, Pharmaceutical Industry, Technology Transfer, Drug Discovery, and Start Ups.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial